Thursday, February 2, 2017

BRIEF-AstraZeneca CEO says MYSTIC cancer drug trial "not binary"

Feb 2 (Reuters) - Astrazeneca CEO Pascal Soriot told

reporters after Q4 results:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)